Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7032371rdf:typepubmed:Citationlld:pubmed
pubmed-article:7032371lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7032371lifeskim:mentionsumls-concept:C0022271lld:lifeskim
pubmed-article:7032371lifeskim:mentionsumls-concept:C0004096lld:lifeskim
pubmed-article:7032371lifeskim:mentionsumls-concept:C0003241lld:lifeskim
pubmed-article:7032371lifeskim:mentionsumls-concept:C0003330lld:lifeskim
pubmed-article:7032371lifeskim:mentionsumls-concept:C0598322lld:lifeskim
pubmed-article:7032371pubmed:issue5 Pt 1lld:pubmed
pubmed-article:7032371pubmed:dateCreated1982-2-12lld:pubmed
pubmed-article:7032371pubmed:abstractTextThirty-eight of 97 asthmatic patients, seven of 26 normal subjects and two of 39 patients with chronic obstructive pulmonary disease (COPD) were found to have antibodies to one or more of the inhalant fungi and candida antigens assayed by both immunodiffusion and counterimmune electrophoresis. Atopy was demonstrated in 33 of the 38 asthmatic patients with antibodies. Eleven asthmatics had anti-alternaria antibodies while only two reacted to aspergillus.lld:pubmed
pubmed-article:7032371pubmed:languageenglld:pubmed
pubmed-article:7032371pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7032371pubmed:citationSubsetIMlld:pubmed
pubmed-article:7032371pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7032371pubmed:statusMEDLINElld:pubmed
pubmed-article:7032371pubmed:monthNovlld:pubmed
pubmed-article:7032371pubmed:issn0003-4738lld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:FeldmanMMlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:SegalEElld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:MazarAAlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:MarcusJJlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:SchuhMMlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:BaumG LGLlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:GlazerIIlld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:KuttinEElld:pubmed
pubmed-article:7032371pubmed:authorpubmed-author:YaronPPlld:pubmed
pubmed-article:7032371pubmed:issnTypePrintlld:pubmed
pubmed-article:7032371pubmed:volume47lld:pubmed
pubmed-article:7032371pubmed:ownerNLMlld:pubmed
pubmed-article:7032371pubmed:authorsCompleteYlld:pubmed
pubmed-article:7032371pubmed:pagination361-4lld:pubmed
pubmed-article:7032371pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:meshHeadingpubmed-meshheading:7032371-...lld:pubmed
pubmed-article:7032371pubmed:year1981lld:pubmed
pubmed-article:7032371pubmed:articleTitleAntibodies to inhalant fungal antigens in patients with asthma in Israel.lld:pubmed
pubmed-article:7032371pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7032371pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed